CompletedNot Applicable

Quality of Life After Transanal Total Mesorectal Excision Compared to Traditional Total Mesorectal Excision

Switzerland249 participantsStarted 2024-08-01

Plain-language summary

The improvement in prognosis of rectal cancer through modern therapy modalities rises questions regarding quality of life (QoL) and functional outcomes. Evidence for long-term QoL and functional outcomes of transanal total mesorectal excision (taTME) is not provided in current literature. This study will compare short-term and long-term QoL and functional outcomes after taTME compared to traditional abdominal TME (laparoscopic, robotic, and open approach)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * elective total mesorectal excision followed by reconstruction with anastomosis for primary rectal cancer Exclusion Criteria: * diagnoses other than rectal cancer * recurrent rectal cancer * partial mesorectal excision * discontinuity resection (no anastomosis) * incomplete TNM staging information * metastatic cancer * 30-day mortality * lack of quality of life data * patient decline * age under 18 years

What they're measuring

Quality of life (QoL)

Timeframe: 5 years after initial operation

Trial details

NCT IDNCT06505863

SponsorCantonal Hospital of St. Gallen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-01

View on ClinicalTrials.gov More Rectal Cancer trials